Learn key considerations for the use of ART in pregnancy. Topics include current recommendations and a discussion of the data to support ART options during pregnancy.
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jonah Musa, MBBS, MSCI, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 417 KB
Released: October 20, 2021
Acknowledgements
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare
Leaving the CCO site
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
